Modulation of host immunity by human respiratory syncytial virus virulence factors: A synergic inhibition of both innate and adaptive immunity

Frontiers in Cellular and Infection Microbiology

Volumn 7, Issue AUG, 2017, Pages

  Canedo Marroquín, Gisela ^a   Acevedo Acevedo, Orlando ^a   Rey Jurado, Emma ^a   Saavedra, Juan M ^a   Lay, Margarita K ^a,b   Bueno, Susan M ^a   Riedel, Claudia A ^c   Kalergis, Alexis M ^a,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE ANTOFAGASTA   (Chile)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Evasion of host immunity; Genes; HRSV; Immunological synapse; N protein

Indexed keywords

ALPHA1 INTERFERON; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; NONSTRUCTURAL PROTEIN 2; PHOSPHOPROTEIN; RNA POLYMERASE; VIRULENCE FACTOR; GLYCOPROTEIN; INTERFERON; M2-2 PROTEIN, RESPIRATORY SYNCYTIAL VIRUS; NUCLEOPROTEIN; ONCOPROTEIN; RNA DIRECTED RNA POLYMERASE; SMALL HYDROPHOBIC PROTEIN, VIRUS; VIRAL PROTEIN; VIRUS FUSION PROTEIN;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL INFILTRATION; CELL PROLIFERATION; HOSPITALIZATION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INNATE IMMUNITY; LOWER RESPIRATORY TRACT INFECTION; LUNG PARENCHYMA; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; AGED; CHILD; DENDRITIC CELL; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGICAL SYNAPSE; IMMUNOLOGY; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE; VIROLOGY; VIRUS GENOME;

ADAPTIVE IMMUNITY; AGED; CHILD; DENDRITIC CELLS; GENOME, VIRAL; GLYCOPROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; IMMUNOLOGICAL SYNAPSES; INTERFERON TYPE I; INTERFERONS; LUNG; LYMPHOCYTE ACTIVATION; NUCLEOPROTEINS; PHOSPHOPROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; RETROVIRIDAE PROTEINS, ONCOGENIC; RNA REPLICASE; T-LYMPHOCYTES; VIRAL FUSION PROTEINS; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRULENCE FACTORS;

EID: 85027718212     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2017.00367     Document Type: Review

References (110)

1. Afonso, C. L., Amarasinghe, G. K., Banyai, K., Bao, Y., Basler, C. F., Bavari, S., et al. (2016). Taxonomy of the order Mononegavirales: update 2016. Arch. Virol. 161, 2351-2360. doi: 10.1007/s00705-016-2880-1
2. Anderson, L. J., Hierholzer, J. C., Tsou, C., Hendry, R. M., Fernie, B. F., Stone, Y., et al. (1985). Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect Dis. 151, 626-633. doi: 10.1093/infdis/151.4.626
3. Araujo, G. C., Silva, R. H., Scott, L. P., Araujo, A. S., Souza, F. P., and de Oliveira, R. J. (2016). Structure and functional dynamics characterization of the ion channel of the human respiratory syncytial virus (hRSV) small hydrophobic protein (SH) transmembrane domain by combining molecular dynamics with excited normal modes. J. Mol. Model. 22:286. doi: 10.1007/s00894-016-3150-6
4. Bakker, S. E., Duquerroy, S., Galloux, M., Loney, C., Conner, E., Eléouët, J. F., et al. (2013). The respiratory syncytial virus nucleoprotein-RNA complex forms a left-handed helical nucleocapsid. J. Gen. Virol. 94, 1734-1738. doi: 10.1099/vir.0.053025-0
5. Bakre, A., Wu, W., Hiscox, J., Spann, K., Teng, M. N., and Tripp, R. A. (2015). Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β. J. Gen. Virol. 96, 3179-3191. doi: 10.1099/jgv.0.000261
6. Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T., and Brenner, M. B. (1994). Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372, 691-694. doi: 10.1038/372691a0
7. Bermingham, A., and Collins, P. L. (1999). The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. U.S.A. 96, 11259-11264. doi: 10.1073/pnas.96.20.11259
8. Bhella, D., Ralph, A., Murphy, L. B., and Yeo, R. P. (2002). Significant differences in nucleocapsid morphology within the Paramyxoviridae. J. Gen. Virol. 83, 1831-1839. doi: 10.1099/0022-1317-83-8-1831
9. Bitko, V., Shulyayeva, O., Mazumder, B., Musiyenko, A., Ramaswamy, M., Look, D. C., et al. (2007). Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J. Virol. 81, 1786-1795. doi: 10.1128/JVI.01420-06
10. Boyapalle, S., Wong, T., Garay, J., Teng, M., San Juan-Vergara, H., Mohapatra, S., et al. (2012). Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection. PLoS ONE 7:e29386. doi: 10.1371/journal.pone.0029386
11. Brownlie, R. J., and Zamoyska, R. (2013). T cell receptor signalling networks: branched, diversified and bounded. Nat. Rev. Immunol. 13, 257-269. doi: 10.1038/nri3403
12. Bueno, S. M., Gonzalez, P. A., Pacheco, R., Leiva, E. D., Cautivo, K. M., Tobar, H. E., et al. (2008). Host immunity during RSV pathogenesis. Int. Immunopharmacol. 8, 1320-1329. doi: 10.1016/j.intimp.2008.03.012
13. Bukreyev, A., Whitehead, S. S., Murphy, B. R., and Collins, P. L. (1997). Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71, 8973-8982
14. Bukreyev, A., Yang, L., and Collins, P. L. (2012). The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement. J. Virol. 86, 10880-10884. doi: 10.1128/JVI.01162-12
15. Bukreyev, A., Yang, L., Fricke, J., Cheng, L., Ward, J. M., Murphy, B. R., et al. (2008). The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J. Virol. 82, 12191-12204. doi: 10.1128/JVI.01604-08
16. Cannon, M. J. (1987). Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice. J. Virol. Methods 16, 293-301. doi: 10.1016/0166-0934(87)90014-0
17. Cespedes, P. F., Bueno, S. M., Ramirez, B. A., Gomez, R. S., Riquelme, S. A., Palavecino, C. E., et al. (2014). Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc. Natl. Acad. Sci. U.S.A. 111, E3214-3223. doi: 10.1073/pnas.1400760111
18. Cheng, X., Park, H., Zhou, H., and Jin, H. (2005). Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication. J. Virol. 79, 13943-13952. doi: 10.1128/JVI.79.22.13943-13952.2005
19. Chirkova, T., Boyoglu-Barnum, S., Gaston, K. A., Malik, F. M., Trau, S. P., Oomens, A. G., et al. (2013). Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J. Virol. 87, 13466-13479. doi: 10.1128/JVI.01741-13
20. Chirkova, T., Lin, S., Oomens, A. G., Gaston, K. A., Boyoglu-Barnum, S., Meng, J., et al. (2015). CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J. Gen. Virol. 96, 2543-2556. doi: 10.1099/vir.0.000218
21. Collins, P. L., and Graham, B. S. (2008). Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82, 2040-2055. doi: 10.1128/JVI.01625-07
22. Collins, P. L., Hill, M. G., Camargo, E., Grosfeld, H., Chanock, R. M., and Murphy, B. R. (1995). Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. U.S.A. 92, 11563-11567. doi: 10.1073/pnas.92.25.11563
23. Collins, P. L., and Mottet, G. (1993). Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus. J. Gen. Virol. 74, 1445-1450. doi: 10.1099/0022-1317-74-7-1445
24. Cyster, J. G., Shotton, D. M., and Williams, A. F. (1991). The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J. 10, 893-902
25. Dakhama, A., Park, J. W., Taube, C., Joetham, A., Balhorn, A., Miyahara, N., et al. (2005). The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J. Immunol. 175, 1876-1883. doi: 10.4049/jimmunol.175.3.1876
26. Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B., et al. (1998). Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16, 523-544. doi: 10.1146/annurev.immunol.16.1.523
27. Deshpande, S. A., and Northern, V. (2003). The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch. Dis. Child. 88, 1065-1069. doi: 10.1136/adc.88.12.1065
28. Dhar, J., Cuevas, R. A., Goswami, R., Zhu, J., Sarkar, S. N., and Barik, S. (2015). 2'-5'-oligoadenylate synthetase-like protein inhibits respiratory syncytial virus replication and is targeted by the viral nonstructural protein 1. J. Virol. 89, 10115-10119. doi: 10.1128/JVI.01076-15
29. Elliott, J., Lynch, O. T., Suessmuth, Y., Qian, P., Boyd, C. R., Burrows, J. F., et al. (2007). Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J. Virol. 81, 3428-3436. doi: 10.1128/JVI.02303-06
30. Espinoza, J. A., Bohmwald, K., Céspedes, P. F., Riedel, C. A., Bueno, S. M., and Kalergis, A. M. (2014). Modulation of host adaptive immunity by hRSV proteins. Virulence 5, 740-751. doi: 10.4161/viru.32225
31. Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., and Walsh, E. E. (2005). Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352, 1749-1759. doi: 10.1056/NEJMoa043951
32. Fearns, R., Peeples, M. E., and Collins, P. L. (1997). Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 236, 188-201. doi: 10.1006/viro.1997.8734
33. Feldman, S. A., Hendry, R. M., and Beeler, J. A. (1999). Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J. Virol. 73, 6610-6617
34. Fix, J., Galloux, M., Blondot, M. L., and Eleouet, J. F. (2011). The insertion of fluorescent proteins in a variable region of respiratory syncytial virus L polymerase results in fluorescent and functional enzymes but with reduced activities. Open Virol. J. 5, 103-108. doi: 10.2174/1874357901105010103
35. Förster, A., Maertens, G. N., Farrell, P. J., and Bajorek, M. (2015). Dimerization of matrix protein is required for budding of respiratory syncytial virus. J. Virol. 89, 4624-4635. doi: 10.1128/JVI.03500-14
36. Fuentes, S., Tran, K. C., Luthra, P., Teng, M. N., and He, B. (2007). Function of the respiratory syncytial virus small hydrophobic protein. J. Virol. 81, 8361-8366. doi: 10.1128/JVI.02717-06
37. Galloux, M., Gabiane, G., Sourimant, J., Richard, C. A., England, P., Moudjou, M., et al. (2015). Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein. J. Virol. 89, 3484-3496. doi: 10.1128/JVI.03666-14
38. Galloux, M., Tarus, B., Blazevic, I., Fix, J., Duquerroy, S., and Eleouet, J. F. (2012). Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial nucleoprotein. J. Virol. 86, 8375-8387. doi: 10.1128/JVI.00058-12
39. Gan, S. W., Ng, L., Lin, X., Gong, X., and Torres, J. (2008). Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain. Protein Sci. 17, 813-820. doi: 10.1110/ps.073366208
40. Gan, S. W., Tan, E., Lin, X., Yu, D., Wang, J., Tan, G. M. Y., et al. (2012). The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels. J. Biol. Chem. 287, 24671-24689. doi: 10.1074/jbc.M111.332791
41. García-Sastre, A., and Biron, C. A. (2006). Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312, 879-882. doi: 10.1126/science.1125676
42. Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299. doi: 10.1016/0092-8674(94)90336-0
43. Ghildyal, R., Ho, A., and Jans, D. A. (2006). Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol. Rev. 30, 692-705. doi: 10.1111/j.1574-6976.2006.00025.x
44. Ghildyal, R., Mills, J., Murray, M., Vardaxis, N., and Meanger, J. (2002). Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J. Gen. Virol. 83, 753-757. doi: 10.1099/0022-1317-83-4-753
45. Glezen, W. P., Taber, L. H., Frank, A. L., and Kasel, J. A. (1986). Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child 140, 543-546. doi: 10.1001/archpedi.1986.02140200053026
46. Gonzalez, P. A., Prado, C. E., Leiva, E. D., Carreno, L. J., Bueno, S. M., Riedel, C. A., et al. (2008). Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 105, 14999-15004. doi: 10.1073/pnas.0802555105
47. Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., et al. (1999). The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221-227. doi: 10.1126/science.285.5425.221
48. Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., et al. (2015). Pillars article: the immunological synapse: a molecular machine controlling T cell activation. science. 1999. 285, 221-227. J. Immunol. 194, 4066-4072
49. Griffiths, C., Drews, S. J., and Marchant, D. J. (2017). Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin. Microbiol. Rev. 30, 277-319. doi: 10.1128/CMR.00010-16
50. Hall, C. B. (2001). Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344, 1917-1928. doi: 10.1056/NEJM200106213442507
51. Harcourt, J., Alvarez, R., Jones, L. P., Henderson, C., Anderson, L. J., and Tripp, R. A. (2006). Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J. Immunol. 176, 1600-1608. doi: 10.4049/jimmunol.176.3.1600
52. Hastie, M. L., Headlam, M. J., Patel, N. B., Bukreyev, A. A., Buchholz, U. J., Dave, K. A., et al. (2012). The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways. Mol. Cell. Proteomics 11, 108-127. doi: 10.1074/mcp.M111.015909
53. Hughes, M. M., Yassai, M., Sedy, J. R., Wehrly, T. D., Huang, C. Y., Kanagawa, O., et al. (2003). T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction. Eur. J. Immunol. 33, 1568-1575. doi: 10.1002/eji.200323961
54. Iannello, A., Debbeche, O., Martin, E., Attalah, L. H., Samarani, S., and Ahmad, A. (2006). Viral strategies for evading antiviral cellular immune responses of the host. J. Leukoc. Biol. 79, 16-35. doi: 10.1189/jlb.0705397
55. Jafri, H. S., Chavez-Bueno, S., Mejias, A., Gomez, A. M., Rios, A. M., Nassi, S. S., et al. (2004). Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J. Infect. Dis. 189, 1856-1865. doi: 10.1086/386372
56. Janeway, C. A. Jr., Travers, P., Walport, M., et al. (2001). Immunobiology: The Immune System in Health and Disease. 5th edition. New York: Garland Science. Available online at: https://www.ncbi.nlm.nih.gov/books/NBKjournalabbrev10757/
57. Jie, Z., Dinwiddie, D. L., Senft, A. P., and Harrod, K. S. (2011). Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus. Virus Res. 156, 127-133. doi: 10.1016/j.virusres.2011.01.007
58. Johnson, S. M., McNally, B. A., Ioannidis, I., Flano, E., Teng, M. N., Oomens, A. G., et al. (2015). Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures. PLoS Pathog. 11:e1005318. doi: 10.1371/journal.ppat.1005318
59. Karron, R. A., Buonagurio, D. A., Georgiu, A. F., Whitehead, S. S., Adamus, J. E., Clements-Mann, M. L., et al. (1997). Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. U.S.A. 94, 13961-13966. doi: 10.1073/pnas.94.25.13961
60. Kiss, G., Holl, J. M., Williams, G. M., Alonas, E., Vanover, D., Lifland, A. W., et al. (2014). Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. J. Virol. 88, 7602-7617. doi: 10.1128/JVI.00256-14
61. Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., et al. (2012). MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717-723. doi: 10.1038/nature11605
62. Klausner, R. D., Donaldson, J. G., and Lippincott-Schwartz, J. (1992). Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116, 1071-1080. doi: 10.1083/jcb.116.5.1071
63. Knapp, B., Demharter, S., Esmaielbeiki, R., and Deane, C. M. (2015). Current status and future challenges in T-cell receptor/peptide/MHC molecular dynamics simulations. Brief. Bioinformatics 16, 1035-1044. doi: 10.1093/bib/bbv005
64. Kolokoltsov, A. A., Deniger, D., Fleming, E. H., Roberts, N. J., Karpilow, J. M., and Davey, R. A. (2007). Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J. Virol. 81, 7786-7800. doi: 10.1128/JVI.02780-06
65. Kotelkin, A., Belyakov, I. M., Yang, L., Berzofsky, J. A., Collins, P. L., and Bukreyev, A. (2006). The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response. J. Virol. 80, 5958-5967. doi: 10.1128/JVI.00181-06
66. Krzyzaniak, M. A., Zumstein, M. T., Gerez, J. A., Picotti, P., and Helenius, A. (2013). Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 9:e1003309. doi: 10.1371/journal.ppat.1003309
67. Kumar, R., Ferez, M., Swamy, M., Arechaga, I., Rejas, M. T., Valpuesta, J. M., et al. (2011). Increased sensitivity of antigen-experienced T cells through the enrichment of oligomeric T cell receptor complexes. Immunity 35, 375-387. doi: 10.1016/j.immuni.2011.08.010
68. Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., et al. (2000). Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1, 398-401. doi: 10.1038/80833
69. Lambert, L., Sagfors, A. M., Openshaw, P. J., and Culley, F. J. (2014). Immunity to RSV in Early-Life. Front. Immunol. 5:466. doi: 10.3389/fimmu.2014.00466
70. Levine, S., Klaiber-Franco, R., and Paradiso, P. R. (1987). Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68(Pt 9), 2521-2524. doi: 10.1099/0022-1317-68-9-2521
71. Lin, Y., Bright, A. C., Rothermel, T. A., and He, B. (2003). Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J. Virol. 77, 3371-3383. doi: 10.1128/JVI.77.6.3371-3383.2003
72. Ling, Z., Tran, K. C., Arnold, J. J., and Teng, M. N. (2008). Purification and characterization of recombinant human respiratory syncytial virus nonstructural protein NS1. Protein Expr. Purif. 57, 261-270. doi: 10.1016/j.pep.2007.09.017
73. Ling, Z., Tran, K. C., and Teng, M. N. (2009). Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83, 3734-3742. doi: 10.1128/JVI.02434-08
74. Lo, M. S., Brazas, R. M., and Holtzman, M. J. (2005). Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79, 9315-9319. doi: 10.1128/JVI.79.14.9315-9319.2005
75. Lofland, J. H., O'Connor, J. P., Chatterton, M. L., Moxey, E. D., Paddock, L. E., Nash, D. B., et al. (2000). Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis. Clin. Ther. 22, 1357-1369. doi: 10.1016/S0149-2918(00)83032-5
76. Losfeld, M. E., Khoury, D. E., Mariot, P., Carpentier, M., Krust, B., Briand, J. P., et al. (2009). The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells. Exp. Cell Res. 315, 357-369. doi: 10.1016/j.yexcr.2008.10.039
77. McCall, M. N., Shotton, D. M., and Barclay, A. N. (1992). Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies. Immunology 76, 310-317
78. McLellan, J. S., Ray, W. C., and Peeples, M. E. (2013). Structure and function of respiratory syncytial virus surface glycoproteins. Curr. Top. Microbiol. Immunol. 372, 83-104. doi: 10.1007/978-3-642-38919-1_4
79. Melero, J. A., Garcia-Barreno, B., Martinez, I., Pringle, C. R., and Cane, P. A. (1997). Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J. Gen. Virol. 78(Pt 10), 2411-2418. doi: 10.1099/0022-1317-78-10-2411
80. Mionnet, C., Buatois, V., Kanda, A., Milcent, V., Fleury, S., Lair, D., et al. (2010). CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat. Med. 16, 1305-1312. doi: 10.1038/nm.2253
81. Money, V. A., McPhee, H. K., Mosely, J. A., Sanderson, J. M., and Yeo, R. P. (2009). Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction. Proc. Natl. Acad. Sci. U.S.A. 106, 4441-4446. doi: 10.1073/pnas.0805740106
82. Mufson, M. A., Orvell, C., Rafnar, B., and Norrby, E. (1985). Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol 66(Pt 10), 2111-2124. doi: 10.1099/0022-1317-66-10-2111
83. Muller, N., Avota, E., Schneider-Schaulies, J., Harms, H., Krohne, G., and Schneider-Schaulies, S. (2006). Measles virus contact with T cells impedes cytoskeletal remodeling associated with spreading, polarization, and CD3 clustering. Traffic 7, 849-858. doi: 10.1111/j.1600-0854.2006.00426.x
84. Munir, S., Hillyer, P., Le Nouën, C., Buchholz, U. J., Rabin, R. L., Collins, P. L., et al. (2011). Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog. 7:e1001336. doi: 10.1371/journal.ppat.1001336
85. Munir, S., Le Nouen, C., Luongo, C., Buchholz, U. J., Collins, P. L., and Bukreyev, A. (2008). Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J. Virol. 82, 8780-8796. doi: 10.1128/JVI.00630-08
86. Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., et al. (2010). Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375, 1545-1555. doi: 10.1016/S0140-6736(10)60206-1
87. Openshaw, P. J., and Tregoning, J. S. (2005). Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 18, 541-555. doi: 10.1128/CMR.18.3.541-555.2005
88. Papadopoulos, E. J., Sassetti, C., Saeki, H., Yamada, N., Kawamura, T., Fitzhugh, D. J., et al. (1999). Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur. J. Immunol. 29, 2551-2559. doi: 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T
89. Pullan, C. R., and Hey, E. N. (1982). Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br. Med. J. 284, 1665-1669. doi: 10.1136/bmj.284.6330.1665
90. Rallabhandi, P., Phillips, R. L., Boukhvalova, M. S., Pletneva, L. M., Shirey, K. A., Gioannini, T. L., et al. (2012). Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. MBio 3, e00218-12. doi: 10.1128/mBio.00218-12
91. Ramaswamy, M., Shi, L., Varga, S. M., Barik, S., Behlke, M. A., and Look, D. C. (2006). Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344, 328-339. doi: 10.1016/j.virol.2005.09.009
92. Razinkov, V., Huntley, C., Ellestad, G., and Krishnamurthy, G. (2002). RSV entry inhibitors block F-protein mediated fusion with model membranes. Antiviral Res. 55, 189-200. doi: 10.1016/S0166-3542(02)00050-5
93. Ren, J., Liu, T., Pang, L., Li, K., Garofalo, R. P., Casola, A., et al. (2011). A novel mechanism for the inhibition of interferon regulatory factor-3-dependent gene expression by human respiratory syncytial virus NS1 protein. J. Gen. Virol. 92, 2153-2159. doi: 10.1099/vir.0.032987-0
94. Rixon, H. W., Brown, G., Aitken, J., McDonald, T., Graham, S., and Sugrue, R. J. (2004). The small hydrophobic (SH) protein accumulates within lipid-raft structures of the Golgi complex during respiratory syncytial virus infection. J. Gen. Virol. 85(Pt 5), 1153-1165. doi: 10.1099/vir.0.19769-0
95. Russell, R. F., McDonald, J. U., Ivanova, M., Zhong, Z., Bukreyev, A., and Tregoning, J. S. (2015). The partial attenuation of Small Hydrophobic (SH) gene deleted RSV is associated with elevated IL-1β responses. J. Virol. 89, 8974-8981. doi: 10.1128/JVI.01070-15
96. Siegle, J. S., Hansbro, N., Herbert, C., Rosenberg, H. F., Domachowske, J. B., Asquith, K. L., et al. (2010). Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir. Res. 11:14. doi: 10.1186/1465-9921-11-14
97. Sigurs, N., Aljassim, F., Kjellman, B., Robinson, P. D., Sigurbergsson, F., Bjarnason, R., et al. (2010). Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65, 1045-1052. doi: 10.1136/thx.2009.121582
98. Spann, K. M., Tran, K. C., and Collins, P. L. (2005). Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 79, 5353-5362. doi: 10.1128/JVI.79.9.5353-5362.2005
99. Spann, K. M., Tran, K. C., Chi, B., Rabin, R. L., and Collins, L. (2004). Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78, 4363-4369. doi: 10.1128/JVI.78.8.4363-4369.2004
100. Swedan, S., Andrews, J., Majumdar, T., Musiyenko, A., and Barik, S. (2011). Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location. J. Virol. 85, 10090-10100. doi: 10.1128/JVI.00413-11
101. Tawar, R. G., Duquerroy, S., Vonrhein, C., Varela, P. F., Damier-Piolle, L., Castagne, N., et al. (2009). Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 326, 1279-1283. doi: 10.1126/science.1177634
102. Tayyari, F., Marchant, D., Moraes, T. J., Duan, W., Mastrangelo, P., and Hegele, R. G. (2011). Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17, 1132-1135. doi: 10.1038/nm.2444
103. Techaarpornkul, S., Barretto, N., and Peeples, M. E. (2001). Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75, 6825-6834. doi: 10.1128/JVI.75.15.6825-6834.2001
104. Thoulouze, M. I., Sol-Foulon, N., Blanchet, F., Dautry-Varsat, A., Schwartz, O., and Alcover, A. (2006). Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 24, 547-561. doi: 10.1016/j.immuni.2006.02.016
105. Triantafilou, K., Kar, S., Vakakis, E., Kotecha, S., and Triantafilou, M. (2013). Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax 68, 66-75. doi: 10.1136/thoraxjnl-2012-202182
106. Tripp, R. A., Jones, L. P., Haynes, L. M., Zheng, H., Murphy, P. M., and Anderson, L. J. (2001). CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2, 732-738. doi: 10.1038/90675
107. Varma, R., Campi, G., Yokosuka, T., Saito, T., and Dustin, M. L. (2006). T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25, 117-127. doi: 10.1016/j.immuni.2006.04.010
108. Whelan, J. N., Tran, K. C., van Rossum, D. B., and Teng, M. N. (2016). Identification of respiratory syncytial virus nonstructural protein 2 residues essential for exploitation of the host ubiquitin system and inhibition of innate immune responses. J. Virol. 90, 6453-6463. doi: 10.1128/JVI.00423-16
109. Wu, P., and Hartert, T. V. (2011). Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev. Anti Infect. Ther. 9, 731-745. doi: 10.1586/eri.11.92
110. Zhang, Y., Yang, L., Wang, H., Zhang, G., and Sun, X. (2016). Respiratory syncytial virus non-structural protein 1 facilitates virus replication through miR-29a-mediated inhibition of interferon-a receptor. Biochem. Biophys. Res. Commun. 478, 1436-1441. doi: 10.1016/j.bbrc.2016.08.142